pravastatin has been researched along with Colitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gilmour, H; Mukhopadhya, A; Plevris, J | 1 |
| Alexander, JS; Bharwani, S; Carter, P; Elrod, JW; Grisham, MB; Harada, H; Joh, T; Jordan, P; Manas, K; Sasaki, M; Warren, A; Wolcott, M | 1 |
2 other study(ies) available for pravastatin and Colitis
| Article | Year |
|---|---|
Pravastatin-induced colitis.
Topics: Aged, 80 and over; Colitis; Colonoscopy; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pravastatin | 2008 |
The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor pravastatin reduces disease activity and inflammation in dextran-sulfate induced colitis.
Topics: Animals; Cell Adhesion Molecules; Cell Membrane Permeability; Cholesterol; Colitis; Dextran Sulfate; Disease Models, Animal; Enzyme Inhibitors; Epithelial Cells; Gene Expression; Hydroxymethylglutaryl CoA Reductases; Immunoglobulins; Immunohistochemistry; Inflammation; Mice; Mice, Inbred C57BL; Mice, Knockout; Mucoproteins; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Pravastatin; RNA, Messenger | 2003 |